Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 2
1952 1
1953 5
1954 3
1955 2
1956 2
1957 5
1958 3
1959 7
1960 6
1961 1
1962 13
1963 11
1964 17
1965 17
1966 4
1967 10
1968 8
1969 11
1970 9
1971 8
1972 10
1973 4
1974 6
1975 14
1976 7
1977 18
1978 13
1979 17
1980 11
1981 15
1982 16
1983 11
1984 20
1985 36
1986 45
1987 48
1988 70
1989 73
1990 70
1991 79
1992 90
1993 95
1994 111
1995 120
1996 146
1997 148
1998 175
1999 189
2000 216
2001 224
2002 270
2003 299
2004 387
2005 478
2006 552
2007 607
2008 691
2009 809
2010 952
2011 1089
2012 1163
2013 1363
2014 1431
2015 1408
2016 1483
2017 1550
2018 1710
2019 1865
2020 2014
2021 2219
2022 2474
2023 2287
2024 920

Text availability

Article attribute

Article type

Publication date

Search Results

26,958 results

Results by year

Filters applied: . Clear all
Page 1
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
Domachowske J, Madhi SA, Simões EAF, Atanasova V, Cabañas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, Chang Y, Leach A, Takas T, Yuan Y, Griffin MP, Mankad VS, Villafana T; MEDLEY Study Group. Domachowske J, et al. Among authors: chang y. N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186. N Engl J Med. 2022. PMID: 35235733 Clinical Trial. No abstract available.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: chang yh. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators. Rini BI, et al. Among authors: chang yh. N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779529 Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: chang yh. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
[Autoimmune bullous diseases in children].
Bruschi L, Minisini F, Nidegger A, Dubois J, Iselin C, Chang YT, Guenova E, Morren MA. Bruschi L, et al. Among authors: chang yt. Rev Med Suisse. 2024 Mar 27;20(867):638-647. doi: 10.53738/REVMED.2024.20.867.638. Rev Med Suisse. 2024. PMID: 38563538 Review. French.
Roles and mechanisms of optineurin in bone metabolism.
Jin J, Huang R, Chang Y, Yi X. Jin J, et al. Among authors: chang y. Biomed Pharmacother. 2024 Mar;172:116258. doi: 10.1016/j.biopha.2024.116258. Epub 2024 Feb 12. Biomed Pharmacother. 2024. PMID: 38350370 Free article. Review.
TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf.
Chang Y, Bach L, Hasiuk M, Wen L, Elmzzahi T, Tsui C, Gutiérrez-Melo N, Steffen T, Utzschneider DT, Raj T, Jost PJ, Heink S, Cheng J, Burton OT, Zeiträg J, Alterauge D, Dahlström F, Becker JC, Kastl M, Symeonidis K, van Uelft M, Becker M, Reschke S, Krebs S, Blum H, Abdullah Z, Paeschke K, Ohnmacht C, Neumann C, Liston A, Meissner F, Korn T, Hasenauer J, Heissmeyer V, Beyer M, Kallies A, Jeker LT, Baumjohann D. Chang Y, et al. Sci Immunol. 2024 Mar;9(93):eadd4818. doi: 10.1126/sciimmunol.add4818. Epub 2024 Mar 1. Sci Immunol. 2024. PMID: 38427718
26,958 results
You have reached the last available page of results. Please see the User Guide for more information.